Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
ADHD
MedTech
Akili axes 46 workers, slims prescription video game pipeline
Akili is kicking off 2023 with a goal of shrinking its operational footprint in a trade-off that will cost 46 jobs and several pipeline projects.
Andrea Park
Jan 17, 2023 10:40am
In struggling Vallon, GRI Bio spots opportunity to reach Nasdaq
Dec 14, 2022 8:27am
Study brings Akili's ADHD digital therapeutic tech to lupus
Jul 15, 2022 10:35am
Akili to take prescription video game tech public in $1B SPAC
Jan 26, 2022 10:05am
Akili adds inattention treatment to prescription game slate
Aug 17, 2021 11:53am
Akili snags $160M for prescription video game to treat ADHD
May 26, 2021 9:31am
